Deepa Ramachandran, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 28
- 8 carriers
- Office
- 1
- Since medical school
- 23 years
- Graduated 2003
Offices
1 location
Looking this up.
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
28 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ramachandran’s office at (408) 335-7640 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
28 of 28 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence G55010 · Cancelled
Licence status: Cancelled · since 1985 · National University Faculty of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$19,080
Medicare paid this office $19,080 for 65 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 63 | $11,916 | $83 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 32 | $4,781 | $149 |
| Short return visit (20+ min) | 13 | $503 | $36 |
Who their Medicare patients are
65 Original Medicare patients in 2024. Average age 75 · Women 66% · Health risk score 1.03. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 75% · Coronary heart disease 28% · Cancer 18% · Atrial fibrillation 18%.
The office billed $41,685, Medicare allowed $25,614 and paid $19,080; for 217 services of 14 kinds; $1,244 of it was for drugs given in the office and $17,836 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 65 | 217 | 75 | 1.03 | $41,685 | $19,080 |
| 2023 | 74 | 208 | 74 | 0.87 | $38,965 | $18,098 |
| 2022 | 97 | 322 | 74 | 0.91 | $63,660 | $32,566 |
| 2021 | 85 | 259 | 74 | 0.99 | $50,520 | $27,249 |
| 2020 | 96 | 379 | 73 | 0.96 | $71,625 | $32,998 |
| 2019 | 112 | 478 | 73 | 0.86 | $89,210 | $41,762 |
| 2018 | 126 | 520 | 73 | 0.80 | $90,828 | $43,359 |
| 2017 | 110 | 383 | 73 | 1.01 | $62,591 | $28,776 |
| 2016 | 155 | 586 | 73 | 1.00 | $109,255 | $49,832 |
| 2015 | 116 | 401 | 73 | 1.03 | $76,241 | $33,778 |
| 2014 | 127 | 615 | 72 | 1.11 | $132,506 | $62,411 |
| 2013 | 91 | 341 | 71 | 0.98 | $79,141 | $36,932 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 68 | $10,707 | $82 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $3,999 | $148 |
| Short return visit (20+ min) | 19 | $1,133 | $54 |
2022: 3 services
| Return visit (30+ min) | 91 | $21,359 | $95 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 32 | $4,815 | $150 |
| Short return visit (20+ min) | 17 | $1,600 | $76 |
2021: 3 services
| Return visit (30+ min) | 77 | $15,885 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 43 | $6,859 | $160 |
| Short return visit (20+ min) | 20 | $1,802 | $82 |
2020: 4 services
| Return visit (30+ min) | 90 | $22,543 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 26 | $3,645 | $140 |
| Short return visit (20+ min) | 19 | $1,208 | $58 |
| Administration of influenza virus vaccine | 12 | $292 | $21 |
2019: 10 services
| Return visit (30+ min) | 97 | $22,622 | $87 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 56 | $7,789 | $139 |
| Pneumococcal vaccine, 13-valent | 14 | $2,914 | $208 |
| Long return visit (40+ min) | 19 | $2,596 | $137 |
| New patient visit (45+ min) | 15 | $1,783 | $119 |
| Short return visit (20+ min) | 17 | $994 | $45 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 16 | $441 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $281 | $15 |
| Administration of pneumococcal vaccine | 12 | $246 | $21 |
| Administration of vaccine | 14 | $213 | $15 |
2018: 10 services
| Return visit (30+ min) | 97 | $18,412 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 54 | $7,354 | $136 |
| Short return visit (20+ min) | 68 | $6,281 | $60 |
| Pneumococcal vaccine, 13-valent | 23 | $4,513 | $196 |
| New patient visit (45+ min) | 11 | $1,492 | $136 |
| New patient visit (30+ min) | 12 | $933 | $78 |
| Administration of influenza virus vaccine | 19 | $515 | $26 |
| Administration of pneumococcal vaccine | 19 | $489 | $26 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 12 | $306 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $138 | $13 |
2017: 7 services
| Return visit (30+ min) | 68 | $8,077 | $79 |
| Short return visit (20+ min) | 76 | $6,303 | $50 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 47 | $6,253 | $133 |
| Pneumococcal vaccine, 13-valent | 19 | $3,530 | $186 |
| Administration of pneumococcal vaccine | 18 | $581 | $32 |
| Administration of influenza virus vaccine | 18 | $532 | $30 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 13 | $306 | $24 |
2016: 9 services
| Return visit (30+ min) | 85 | $14,411 | $93 |
| Long return visit (40+ min) | 62 | $8,986 | $104 |
| Short return visit (20+ min) | 70 | $8,503 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 55 | $7,420 | $135 |
| New patient visit (45+ min) | 32 | $4,134 | $129 |
| Pneumococcal vaccine, 23-valent | 16 | $1,264 | $79 |
| Influenza vaccine split virus, preservative free | 16 | $670 | $42 |
| Administration of influenza virus vaccine | 20 | $588 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $241 | $15 |
2015: 6 services
| Long return visit (40+ min) | 76 | $15,679 | $118 |
| Return visit (30+ min) | 43 | $4,920 | $89 |
| Short return visit (20+ min) | 40 | $4,260 | $60 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $3,680 | $136 |
| New patient visit (60+ min) | 12 | $1,986 | $166 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $196 | $18 |
2014: 8 services
| Long return visit (40+ min) | 98 | $32,206 | $127 |
| New patient visit (60+ min) | 64 | $11,168 | $174 |
| Return visit (30+ min) | 52 | $7,386 | $96 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 32 | $4,313 | $135 |
| Short return visit (20+ min) | 31 | $2,914 | $68 |
| Administration of influenza virus vaccine | 26 | $768 | $30 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 30 | $406 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $320 | $15 |
2013: 5 services
| Long return visit (40+ min) | 51 | $14,382 | $132 |
| New patient visit (60+ min) | 45 | $8,040 | $179 |
| Return visit (30+ min) | 47 | $7,805 | $93 |
| New patient visit (45+ min) | 23 | $2,740 | $119 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,597 | $133 |
Drugs they prescribed that Part D paid
$42,341
Pharmacies billed $42,341 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (99 of 1,402) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%.
1,315 generic and fewer than 11 brand-name prescriptions · $42,341 in drug cost · 57 antibiotic prescriptions to 33 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rosuvastatin | 125 | $2,558 | $20 |
| Hydrocodone-Acetaminophen | 68 | $1,519 | $22 |
| Levothyroxine | 73 | $881 | $12 |
| Atorvastatin | 66 | $843 | $13 |
| Amlodipine Besylate | 75 | $704 | $9 |
See all 32 drugs
| Rosuvastatin | 125 | $2,558 | $20 |
| Hydrocodone-Acetaminophen | 68 | $1,519 | $22 |
| Levothyroxine | 73 | $881 | $12 |
| Atorvastatin | 66 | $843 | $13 |
| Amlodipine Besylate | 75 | $704 | $9 |
| Losartan | 89 | $641 | $7 |
| Lisinopril | 80 | $630 | $8 |
| Metoprolol | 32 | $523 | $16 |
| Albuterol Sulfate Hfa | 16 | $519 | $32 |
| Gabapentin | 22 | $512 | $23 |
| Fenofibrate | 13 | $496 | $38 |
| Hydrochlorothiazide | 51 | $335 | $7 |
| Metformin | 60 | $307 | $5 |
| Simvastatin | 23 | $295 | $13 |
| Losartan-Hydrochlorothiazide | 13 | $282 | $22 |
| Allopurinol | 18 | $267 | $15 |
| Sertraline | 18 | $244 | $14 |
| Nitrofurantoin Mono-Macro | 13 | $217 | $17 |
| Omeprazole | 12 | $212 | $18 |
| Tramadol | 16 | $167 | $10 |
| Alendronate | 23 | $156 | $7 |
| Azithromycin | 26 | $153 | $6 |
| Oxycodone-Acetaminophen | 12 | $153 | $13 |
| Bupropion Xl | 11 | $147 | $13 |
| Citalopram Hbr | 27 | $145 | $5 |
| Benazepril | 11 | $135 | $12 |
| Glimepiride | 11 | $118 | $11 |
| Alprazolam | 31 | $112 | $4 |
| Clopidogrel | 14 | $108 | $8 |
| Zolpidem | 11 | $97 | $9 |
| Furosemide | 12 | $75 | $6 |
| Lisinopril-Hydrochlorothiazide | 25 | $66 | $3 |
Year by year
| 2024 | 1,402 | 130 | 7% (99) | None | $42,341 |
| 2023 | 1,392 | 131 | 7% (93) | 6% | $50,574 |
| 2022 | 1,393 | 137 | 8% (109) | 7% | $49,183 |
| 2021 | 1,609 | 130 | 6% (99) | 7% | $39,889 |
| 2020 | 1,497 | 135 | 6% (95) | None | $37,481 |
| 2019 | 1,415 | 140 | 4% (62) | None | $46,245 |
| 2018 | 1,519 | 125 | 4% (66) | 16% | $69,931 |
| 2017 | 1,491 | 124 | 4% (55) | 16% | $77,174 |
| 2016 | 1,318 | 134 | 4% (50) | None | $86,670 |
| 2015 | 1,022 | 101 | 4% (39) | None | $82,510 |
| 2014 | 878 | 89 | 2% (13) | 22% | $71,146 |
| 2013 | 475 | 62 | None | None | $35,225 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 32 drugs
| Rosuvastatin | 122 | $3,290 | $27 |
| Hydrocodone-Acetaminophen | 69 | $2,357 | $34 |
| Atorvastatin | 69 | $1,304 | $19 |
| Amlodipine Besylate | 78 | $1,232 | $16 |
| Losartan | 82 | $1,059 | $13 |
| Levothyroxine | 73 | $1,042 | $14 |
| Lisinopril | 77 | $993 | $13 |
| Metoprolol | 32 | $781 | $24 |
| Simvastatin | 32 | $723 | $23 |
| Albuterol Sulfate Hfa | 17 | $657 | $39 |
| Gabapentin | 24 | $598 | $25 |
| Sumatriptan | 21 | $543 | $26 |
| Omeprazole | 20 | $538 | $27 |
| Fenofibrate | 13 | $482 | $37 |
| Clopidogrel | 17 | $459 | $27 |
| Metformin | 39 | $453 | $12 |
| Losartan-Hydrochlorothiazide | 13 | $372 | $29 |
| Nitrofurantoin Mono-Macro | 11 | $339 | $31 |
| Allopurinol | 12 | $333 | $28 |
| Sertraline | 20 | $292 | $15 |
| Hydrochlorothiazide | 48 | $248 | $5 |
| Azithromycin | 34 | $240 | $7 |
| Lisinopril-Hydrochlorothiazide | 22 | $210 | $10 |
| Alprazolam | 26 | $179 | $7 |
| Zolpidem | 14 | $172 | $12 |
| Paxlovid (Eua) | 16 | $172 | $11 |
| Metoprolol | 12 | $164 | $14 |
| Tramadol | 19 | $141 | $7 |
| Alendronate | 13 | $140 | $11 |
| Atenolol | 12 | $105 | $9 |
| Furosemide | 13 | $39 | $3 |
| Lorazepam | 11 | $31 | $3 |
2022: 31 drugs
| Hydrocodone-Acetaminophen | 88 | $2,572 | $29 |
| Atorvastatin | 86 | $1,805 | $21 |
| Rosuvastatin | 63 | $1,440 | $23 |
| Amlodipine Besylate | 76 | $1,234 | $16 |
| Metoprolol | 45 | $1,157 | $26 |
| Fenofibrate | 19 | $1,153 | $61 |
| Levothyroxine | 62 | $892 | $14 |
| Losartan | 83 | $867 | $10 |
| Lisinopril | 70 | $863 | $12 |
| Gabapentin | 11 | $783 | $71 |
| Simvastatin | 42 | $617 | $15 |
| Clopidogrel | 20 | $451 | $23 |
| Omeprazole | 20 | $441 | $22 |
| Alprazolam | 37 | $432 | $12 |
| Losartan-Hydrochlorothiazide | 14 | $428 | $31 |
| Metformin | 40 | $345 | $9 |
| Lisinopril-Hydrochlorothiazide | 27 | $317 | $12 |
| Allopurinol | 12 | $274 | $23 |
| Atenolol | 19 | $219 | $12 |
| Glimepiride | 15 | $202 | $13 |
| Hydrochlorothiazide | 43 | $195 | $5 |
| Azithromycin | 20 | $163 | $8 |
| Metoprolol | 15 | $156 | $10 |
| Sertraline | 13 | $144 | $11 |
| Zolpidem | 22 | $135 | $6 |
| Tramadol | 15 | $98 | $7 |
| Citalopram Hbr | 13 | $94 | $7 |
| Triamterene-Hydrochlorothiazid | 14 | $91 | $7 |
| Furosemide | 16 | $89 | $6 |
| Alendronate | 14 | $72 | $5 |
| Lovastatin | 11 | $18 | $2 |
2021: 34 drugs
| Hydrocodone-Acetaminophen | 71 | $2,319 | $33 |
| Atorvastatin | 106 | $1,707 | $16 |
| Levothyroxine | 80 | $1,470 | $18 |
| Gabapentin | 15 | $1,460 | $97 |
| Amlodipine Besylate | 100 | $1,101 | $11 |
| Rosuvastatin | 54 | $1,011 | $19 |
| Losartan | 90 | $961 | $11 |
| Metoprolol | 62 | $952 | $15 |
| Fenofibrate | 17 | $897 | $53 |
| Lisinopril | 101 | $869 | $9 |
| Duloxetine | 13 | $802 | $62 |
| Simvastatin | 62 | $519 | $8 |
| Olmesartan Medoxomil | 14 | $487 | $35 |
| Albuterol Sulfate Hfa | 11 | $482 | $44 |
| Metformin | 67 | $449 | $7 |
| Nitrofurantoin Mono-Macro | 11 | $433 | $39 |
| Potassium Chloride | 11 | $379 | $34 |
| Omeprazole | 26 | $365 | $14 |
| Clopidogrel | 21 | $350 | $17 |
| Losartan-Hydrochlorothiazide | 15 | $293 | $20 |
| Alprazolam | 40 | $289 | $7 |
| Alendronate | 21 | $288 | $14 |
| Hydrochlorothiazide | 38 | $163 | $4 |
| Glimepiride | 13 | $158 | $12 |
| Triamterene-Hydrochlorothiazid | 20 | $157 | $8 |
| Tramadol | 23 | $142 | $6 |
| Citalopram Hbr | 26 | $140 | $5 |
| Sertraline | 11 | $139 | $13 |
| Lisinopril-Hydrochlorothiazide | 23 | $139 | $6 |
| Furosemide | 25 | $127 | $5 |
| Lovastatin | 12 | $123 | $10 |
| Zolpidem | 21 | $119 | $6 |
| Tamsulosin | 11 | $108 | $10 |
| Metoprolol | 18 | $82 | $5 |
2020: 36 drugs
| Rosuvastatin | 48 | $2,331 | $49 |
| Levothyroxine | 92 | $1,933 | $21 |
| Atorvastatin | 90 | $1,578 | $18 |
| Hydrocodone-Acetaminophen | 65 | $1,292 | $20 |
| Metoprolol | 44 | $1,167 | $27 |
| Losartan-Hydrochlorothiazide | 11 | $1,124 | $102 |
| Lisinopril | 96 | $944 | $10 |
| Losartan | 48 | $885 | $18 |
| Memantine | 25 | $815 | $33 |
| Amlodipine Besylate | 76 | $703 | $9 |
| Gabapentin | 12 | $658 | $55 |
| Potassium Chloride | 20 | $500 | $25 |
| Simvastatin | 60 | $463 | $8 |
| Metformin | 48 | $462 | $10 |
| Liothyronine | 12 | $456 | $38 |
| Omeprazole | 25 | $356 | $14 |
| Alendronate | 25 | $343 | $14 |
| Triamterene-Hydrochlorothiazid | 21 | $304 | $14 |
| Clopidogrel | 19 | $304 | $16 |
| Pravastatin | 12 | $282 | $23 |
| Levetiracetam | 13 | $274 | $21 |
| Tramadol | 30 | $238 | $8 |
| Lovastatin | 13 | $205 | $16 |
| Hydrochlorothiazide | 29 | $197 | $7 |
| Oxybutynin Chloride | 14 | $176 | $13 |
| Furosemide | 23 | $167 | $7 |
| Sertraline | 11 | $150 | $14 |
| Alprazolam | 34 | $149 | $4 |
| Trazodone | 18 | $125 | $7 |
| Metoprolol | 21 | $118 | $6 |
| Sumatriptan | 11 | $105 | $10 |
| Donepezil | 12 | $99 | $8 |
| Azithromycin | 15 | $95 | $6 |
| Zolpidem | 18 | $73 | $4 |
| Citalopram Hbr | 17 | $69 | $4 |
| Glipizide | 13 | $53 | $4 |
2019: 36 drugs
| Rosuvastatin | 33 | $3,602 | $109 |
| Bystolic | 15 | $2,865 | $191 |
| Levothyroxine | 92 | $2,185 | $24 |
| Atorvastatin | 99 | $1,749 | $18 |
| Metoprolol | 39 | $1,232 | $32 |
| Synthroid | 15 | $1,177 | $78 |
| Venlafaxine Hcl Er | 11 | $940 | $85 |
| Lisinopril | 88 | $912 | $10 |
| Fenofibrate | 19 | $873 | $46 |
| Amlodipine Besylate | 77 | $868 | $11 |
| Metformin | 50 | $849 | $17 |
| Memantine | 24 | $826 | $34 |
| Losartan | 29 | $639 | $22 |
| Omeprazole | 40 | $637 | $16 |
| Simvastatin | 68 | $635 | $9 |
| Hydrocodone-Acetaminophen | 36 | $559 | $16 |
| Glimepiride | 21 | $550 | $26 |
| Tramadol | 26 | $466 | $18 |
| Alfuzosin Hcl Er | 13 | $425 | $33 |
| Pravastatin | 17 | $300 | $18 |
| Triamterene-Hydrochlorothiazid | 24 | $289 | $12 |
| Alendronate | 22 | $281 | $13 |
| Losartan-Hydrochlorothiazide | 22 | $268 | $12 |
| Metoprolol | 21 | $245 | $12 |
| Levetiracetam | 12 | $242 | $20 |
| Sertraline | 22 | $239 | $11 |
| Oxybutynin Chloride | 11 | $237 | $22 |
| Atenolol | 15 | $210 | $14 |
| Esomeprazole Magnesium | 12 | $208 | $17 |
| Hydrochlorothiazide | 18 | $175 | $10 |
| Clopidogrel | 14 | $138 | $10 |
| Azithromycin | 17 | $128 | $8 |
| Donepezil | 13 | $117 | $9 |
| Trazodone | 16 | $96 | $6 |
| Citalopram Hbr | 13 | $93 | $7 |
| Alprazolam | 25 | $76 | $3 |
2018: 37 drugs
| Bystolic | 16 | $2,879 | $180 |
| Rosuvastatin | 21 | $2,321 | $111 |
| Levothyroxine | 99 | $2,152 | $22 |
| Atorvastatin | 98 | $2,040 | $21 |
| Hydrocodone-Acetaminophen | 43 | $1,328 | $31 |
| Synthroid | 27 | $1,286 | $48 |
| Metoprolol | 35 | $1,209 | $35 |
| Metformin | 57 | $908 | $16 |
| Venlafaxine Hcl Er | 12 | $864 | $72 |
| Fenofibrate | 14 | $812 | $58 |
| Memantine | 15 | $810 | $54 |
| Amlodipine Besylate | 59 | $806 | $14 |
| Glimepiride | 33 | $774 | $23 |
| Lisinopril | 77 | $725 | $9 |
| Losartan | 36 | $708 | $20 |
| Alfuzosin Hcl Er | 19 | $601 | $32 |
| Omeprazole | 35 | $590 | $17 |
| Simvastatin | 68 | $588 | $9 |
| Potassium Chloride | 13 | $574 | $44 |
| Ranitidine | 11 | $553 | $50 |
| Pravastatin | 23 | $531 | $23 |
| Levetiracetam | 12 | $316 | $26 |
| Triamterene-Hydrochlorothiazid | 19 | $307 | $16 |
| Atenolol | 29 | $295 | $10 |
| Alendronate | 20 | $285 | $14 |
| Tramadol | 14 | $284 | $20 |
| Valsartan | 19 | $269 | $14 |
| Hydrochlorothiazide | 17 | $240 | $14 |
| Losartan-Hydrochlorothiazide | 15 | $239 | $16 |
| Sertraline | 16 | $186 | $12 |
| Metoprolol | 12 | $148 | $12 |
| Clopidogrel | 18 | $146 | $8 |
| Azithromycin | 18 | $145 | $8 |
| Lovastatin | 13 | $114 | $9 |
| Furosemide | 11 | $92 | $8 |
| Alprazolam | 36 | $58 | $2 |
| Trazodone | 13 | $47 | $4 |
2017: 39 drugs
| Symbicort | 13 | $5,962 | $459 |
| Bystolic | 13 | $2,992 | $230 |
| Levothyroxine | 111 | $2,595 | $23 |
| Rosuvastatin | 20 | $2,118 | $106 |
| Atorvastatin | 87 | $1,742 | $20 |
| Synthroid | 25 | $1,258 | $50 |
| Fenofibrate | 13 | $977 | $75 |
| Metoprolol | 32 | $912 | $29 |
| Metformin | 72 | $779 | $11 |
| Memantine | 12 | $720 | $60 |
| Simvastatin | 76 | $666 | $9 |
| Lisinopril | 63 | $640 | $10 |
| Hydrocodone-Acetaminophen | 34 | $596 | $18 |
| Glimepiride | 29 | $590 | $20 |
| Pravastatin | 30 | $535 | $18 |
| Amlodipine Besylate | 46 | $514 | $11 |
| Venlafaxine Hcl Er | 12 | $466 | $39 |
| Omeprazole | 43 | $464 | $11 |
| Alfuzosin Hcl Er | 11 | $382 | $35 |
| Valsartan | 18 | $368 | $20 |
| Atenolol | 26 | $278 | $11 |
| Lovastatin | 15 | $226 | $15 |
| Levetiracetam | 15 | $208 | $14 |
| Losartan-Hydrochlorothiazide | 12 | $190 | $16 |
| Alendronate | 20 | $179 | $9 |
| Hydrochlorothiazide | 18 | $170 | $9 |
| Losartan | 16 | $148 | $9 |
| Sertraline | 16 | $137 | $9 |
| Metoprolol | 21 | $127 | $6 |
| Clopidogrel | 12 | $122 | $10 |
| Pantoprazole | 12 | $121 | $10 |
| Azithromycin | 13 | $115 | $9 |
| Zolpidem | 18 | $107 | $6 |
| Escitalopram | 18 | $95 | $5 |
| Alprazolam | 23 | $95 | $4 |
| Citalopram Hbr | 12 | $87 | $7 |
| Furosemide | 15 | $83 | $6 |
| Tramadol | 11 | $72 | $7 |
| Lorazepam | 17 | $54 | $3 |
2016: 30 drugs
| Levothyroxine | 98 | $2,601 | $27 |
| Atorvastatin | 79 | $1,671 | $21 |
| Proair Hfa | 15 | $1,463 | $98 |
| Hydrocodone-Acetaminophen | 40 | $1,422 | $36 |
| Fenofibrate | 16 | $1,368 | $86 |
| Metoprolol | 34 | $1,345 | $40 |
| Synthroid | 23 | $1,340 | $58 |
| Tamsulosin | 26 | $707 | $27 |
| Simvastatin | 57 | $553 | $10 |
| Amlodipine Besylate | 47 | $537 | $11 |
| Doxazosin Mesylate | 13 | $504 | $39 |
| Betamethasone Dipropionate | 11 | $473 | $43 |
| Lisinopril | 45 | $471 | $10 |
| Metformin | 53 | $369 | $7 |
| Glimepiride | 17 | $318 | $19 |
| Omeprazole | 23 | $263 | $11 |
| Levetiracetam | 21 | $258 | $12 |
| Lovastatin | 14 | $218 | $16 |
| Triamterene-Hydrochlorothiazid | 14 | $214 | $15 |
| Alprazolam | 28 | $159 | $6 |
| Sertraline | 27 | $159 | $6 |
| Losartan | 11 | $154 | $14 |
| Citalopram Hbr | 19 | $152 | $8 |
| Atenolol | 16 | $117 | $7 |
| Lisinopril-Hydrochlorothiazide | 13 | $116 | $9 |
| Hydrochlorothiazide | 13 | $110 | $8 |
| Azithromycin | 18 | $97 | $5 |
| Alendronate | 11 | $83 | $8 |
| Zolpidem | 12 | $79 | $7 |
| Lorazepam | 12 | $37 | $3 |
2015: 28 drugs
| Symbicort | 13 | $8,343 | $642 |
| Crestor | 15 | $7,293 | $486 |
| Atorvastatin | 64 | $1,496 | $23 |
| Levothyroxine | 56 | $1,489 | $27 |
| Proair Hfa | 17 | $1,469 | $86 |
| Fenofibrate | 14 | $1,142 | $82 |
| Hydrocodone-Acetaminophen | 31 | $964 | $31 |
| Synthroid | 14 | $834 | $60 |
| Valsartan | 11 | $779 | $71 |
| Metformin | 60 | $765 | $13 |
| Tamsulosin | 18 | $748 | $42 |
| Metoprolol | 16 | $579 | $36 |
| Omeprazole | 16 | $414 | $26 |
| Simvastatin | 41 | $407 | $10 |
| Amlodipine Besylate | 25 | $332 | $13 |
| Lisinopril | 36 | $309 | $9 |
| Glyburide | 11 | $204 | $19 |
| Glimepiride | 13 | $175 | $13 |
| Venlafaxine Hcl Er | 11 | $153 | $14 |
| Alendronate | 11 | $152 | $14 |
| Lovastatin | 11 | $152 | $14 |
| Losartan | 12 | $145 | $12 |
| Azithromycin | 15 | $118 | $8 |
| Lorazepam | 26 | $115 | $4 |
| Hydrochlorothiazide | 12 | $115 | $10 |
| Atenolol | 13 | $104 | $8 |
| Lisinopril-Hydrochlorothiazide | 14 | $101 | $7 |
| Alprazolam | 18 | $58 | $3 |
2014: 19 drugs
| Crestor | 17 | $7,772 | $457 |
| Nexium | 11 | $4,503 | $409 |
| Symbicort | 12 | $4,502 | $375 |
| Proair Hfa | 15 | $1,382 | $92 |
| Levothyroxine | 54 | $1,302 | $24 |
| Atorvastatin | 41 | $1,006 | $25 |
| Bd Ultra-Fine Pen Needle | 15 | $848 | $57 |
| Metoprolol | 13 | $847 | $65 |
| Metformin | 36 | $441 | $12 |
| Simvastatin | 39 | $434 | $11 |
| Lisinopril | 34 | $334 | $10 |
| Omeprazole | 16 | $305 | $19 |
| Glimepiride | 17 | $287 | $17 |
| Tamsulosin | 12 | $250 | $21 |
| Amlodipine Besylate | 18 | $244 | $14 |
| Lorazepam | 27 | $114 | $4 |
| Atenolol | 13 | $84 | $6 |
| Citalopram Hbr | 12 | $80 | $7 |
| Alprazolam | 12 | $80 | $7 |
2013: 12 drugs
| Crestor | 17 | $6,156 | $362 |
| Namenda | 16 | $2,122 | $133 |
| Atorvastatin | 18 | $455 | $25 |
| Levothyroxine | 23 | $406 | $18 |
| Simvastatin | 27 | $389 | $14 |
| Hydroxyzine | 12 | $298 | $25 |
| Finasteride | 13 | $185 | $14 |
| Zolpidem | 16 | $163 | $10 |
| Buspirone | 12 | $145 | $12 |
| Metformin | 11 | $140 | $13 |
| Benztropine Mesylate | 12 | $132 | $11 |
| Lisinopril | 12 | $96 | $8 |
Money from drug and device companies
$33 in 2020
| 2020 | 1 | 2 | None | $33 |
| 2019 | 1 | 1 | None | $16 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genentech USA | Xolair | $33 | 2 payments
|
See all 2 published payments
| Genentech USA | Meals · 2020-02-26 | Xolair | $16 |
| Genentech USA | Meals · 2020-01-13 | Xolair | $16 |
See earlier years (2019)
2019: $16
| Genentech USA | Xolair | $16 | 1 payment
|
Professional record
- NPI
- 1356561930
- Licence
- CA 55010California G55010: Cancelled
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 3162 Newberry Dr Ste 30, San Jose, CA, 95118
- NPI first listed
- 2007-04-26
- NPI last updated
- 2019-02-27
This is when the NPI record was last certified, not a medical board exam.